Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2018 · 10-Q
Revenue$2.26M$2.26M+55.7% vs Q2 2017 Net Income$31.17K$31.17K−60.6% vs Q2 2017 EPS Diluted$0.01$0.01— vs Q2 2017 Gross Profit$2,104,108+63.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived$202,535+336.4% Free Cash Flowderived$198,083+342.5% Margins · derivedGross margin93.0%+4.3 pt vs Q2 2017
Operating margin1.4%−6.8 pt vs Q2 2017
Net margin1.4%−4.1 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 13, 2018 · 44 d after period end